Arrowhead Research Corp (NASDAQ:ARWR)

During the Trading Day
6.26 +0.05 / +0.81%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.25 -0.01 / -0.16%
Volume: 6.1K
Health Technology

Company Description

Arrowhead Research Corp. is a biopharmaceutical company developing targeted RNAi therapeutics. It is leveraging its proprietary drug delivery technologies to develop drugs based on the RNA interference mechanism that efficiently silences disease-causing genes. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Research Corp.
225 South Lake Avenue
Pasadena California 91101-3009
P:(626) 304-3400
Investor Relations:



Other institutional31.98%
Mutual fund holders26.90%
Individual stakeholders2.27%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Bruce D. GivenChief Operating Officer
Kenneth Allen MyszkowskiChief Financial Officer
David LewisChief Scientific Officer
Jane DavidsonSecretary & Vice President-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account